- Rank in Search Criteria: 3721
World Rank (Jan-05-2024): 11,801
Market Cap (Jan-05-2024): 0.57 Billion USD
World Rank (Jul-30-2023): 10537
Market Cap (Jul-30-2023): 0.72 Billion USD
World Rank (Jan-2022): 6,446
Market Cap (Jan-2022): 1.92 Billion USDHeadquarters Country: USA Annual Revenue in USD: 0 Million USD
Annual Operating Income in USD: -335 Million USD
Annual Net Income in USD: -332 Million USD
Annual Results for Period ending: Dec-2022 ending yearEmployee Count: 310
Employee Count as of Date: As on 2021
Company Profile: Allogene Therapeutics is a Clinical Stage Biotechnology company. It single minded focus on pioneering the development of allogeneic chimeric antigen receptor T cell therapies for cancer and researchers is dedicated to discovery and translational research, development and cell manufacturing. The headquarters is in USA.
- Rank in Search Criteria: 3722
World Rank (Jan-05-2024): 11,803
Market Cap (Jan-05-2024): 0.57 Billion USD
World Rank (Jul-30-2023): 11188
Market Cap (Jul-30-2023): 0.64 Billion USD
World Rank (Jan-2022): 15,003
Market Cap (Jan-2022): 0.39 Billion USD
- Rank in Search Criteria: 3723
World Rank (Jan-05-2024): 11,813
Market Cap (Jan-05-2024): 0.57 Billion USD
World Rank (Jul-30-2023): 11535
Market Cap (Jul-30-2023): 0.61 Billion USD
World Rank (Jan-2022): 10,610
Market Cap (Jan-2022): 0.81 Billion USD
- Rank in Search Criteria: 3724
World Rank (Jan-05-2024): 11,820
Market Cap (Jan-05-2024): 0.57 Billion USD
World Rank (Jul-30-2023): 12375
Market Cap (Jul-30-2023): 0.53 Billion USD
World Rank (Jan-2022): 12,745
Market Cap (Jan-2022): 0.56 Billion USDHeadquarters Country: USA Annual Revenue in USD: 159 Million USD
Annual Net Income in USD: 158 Million USD
Annual Results for Period ending: Dec-2021 ending yearCompany Profile: Sherborne Investors (Guernsey) C Limited is a Guernsey is an investment and financial services company. The company total assets are 421.6 million GBP as on 2020. The headquarters is in USA.
- Rank in Search Criteria: 3725
World Rank (Jan-05-2024): 11,822
Market Cap (Jan-05-2024): 0.57 Billion USD
World Rank (Jul-30-2023): 6034
Market Cap (Jul-30-2023): 1.85 Billion USD
World Rank (Jan-2022): 8,990
Market Cap (Jan-2022): 1.08 Billion USDHeadquarters Country: USA Annual Revenue in USD: 0 Million USD
Annual Operating Income in USD: -81 Million USD
Annual Net Income in USD: -85 Million USD
Annual Results for Period ending: Dec-2022 ending yearCompany Profile: PureCycle Technologies is a Recycling Process company with plastic waste as a renewable resource. The headquarters is in USA.
- Rank in Search Criteria: 3726
World Rank (Jan-05-2024): 11,825
World Rank (Jul-30-2023): 11825
Market Cap (Jul-30-2023): 0.58 Billion USD
World Rank (Jan-2022): 12,542
Market Cap (Jan-2022): 0.58 Billion USDHeadquarters Country: USA Annual Revenue in USD: 0 Million USD
Annual Net Income in USD: -1 Million USD
Annual Results for Period ending: Dec-2021 ending year
- Rank in Search Criteria: 3727
World Rank (Jan-05-2024): 11,828
Market Cap (Jan-05-2024): 0.57 Billion USD
World Rank (Jul-30-2023): 12499
Market Cap (Jul-30-2023): 0.52 Billion USD
World Rank (Jan-2022): 14,282
Market Cap (Jan-2022): 0.44 Billion USDHeadquarters Country: USA Annual Revenue in USD: 53 Million USD
Annual Operating Income in USD: 48 Million USD
Annual Net Income in USD: 36 Million USD
Annual Results for Period ending: Dec-2022 ending yearCompany Profile: Fidus Investment Corporation is an Externally Managed, Closed End and Non Diversified Management Investment company. The headquarters is in USA.
- Rank in Search Criteria: 3728
World Rank (Jan-05-2024): 11,833
World Rank (Jul-30-2023): 11833
Market Cap (Jul-30-2023): 0.58 Billion USD
World Rank (Jan-2022): 11,641
Market Cap (Jan-2022): 0.67 Billion USDHeadquarters Country: USA Annual Revenue in USD: 2 Million USD
Annual Operating Income in USD: -67 Million USD
Annual Net Income in USD: -105 Million USD
Annual Results for Period ending: Dec-2022 ending yearEmployee Count: 20
Employee Count as of Date: As on 2021
Company Profile: Northwest Biotherapeutics, Inc is a Clinical Stage Biotechnology company focused on the development of personalized cancer vaccines designed to treat a broad range of solid tumor cancers. The company annual revenue is 1.29 million USD and 17 employees as on 2020. The headquarters is in USA.
- Rank in Search Criteria: 3729
World Rank (Jan-05-2024): 11,835
Market Cap (Jan-05-2024): 0.57 Billion USD
World Rank (Jul-30-2023): 12989
Market Cap (Jul-30-2023): 0.48 Billion USD
World Rank (Jan-2022): 17,917
Market Cap (Jan-2022): 0.24 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 3730
World Rank (Jan-05-2024): 11,836
Market Cap (Jan-05-2024): 0.57 Billion USD
World Rank (Jul-30-2023): 11911
Market Cap (Jul-30-2023): 0.57 Billion USD
World Rank (Jan-2022): 11,910
Market Cap (Jan-2022): 0.64 Billion USD